Adult Primary Hepatocellular Carcinoma Terminated Phase 2 Trials for Dasatinib (DB01254)

Also known as: Primary Adult Hepatocellular Carcinoma

IndicationStatusPhase
DBCOND0029159 (Adult Primary Hepatocellular Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00459108Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by SurgeryTreatment